Erowid
 
 
Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Titles containing 'Meth in hole' OR with Authors including 'Meth in hole' OR with Abstract including 'Meth in hole' OR with Keywords including 'Meth in hole'


Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
Burroughs W Letter From A Master Addict To Dangerous Drugs British Journal of A... 1956
van den Brank HAS, Elliot... Radioprotective action of 5-hydroxytryptamine Nature 1958
LE Hollister, JJ Prusmack... Comparison of three psychotropic drugs (Psilocybin, JB-329, and IT-290... J. Nerv. & Ment. Dis... 1960
Doull J, Tricou BJ Studies on the radioprotective effect of serotonin in mice Fed. Proc. 1961
Fuller RW, Hines CW, Mill... Lowering of Brain Serotonin Levels by Chloramphetamines Biochem Pharmacol 1965
Eisner BG The Importance of the Non-Verbal 2nd International Co... 1967
Connell PH Hallucinogens Side effects of drug... 1972
Lopatin DE, Voss EW Anti-Lysergic Antibody: Measurement of Binding Parameters in IgG Fract... Immunochemistry 1974
Jalfre M, Ruch-Monachon M... Methods for Assessing the Interaction of Agents with 5-Hydroxytryptami... Advances in Psychoph... 1974
Rappoport M, Cornish H The Effect of Two Hallucinogens on in Vivo Concentrations of Cyclic AM... Toxicol. appl. Pharm... 1974
Kaplan J, Mandel LR, Stil... Blood and urine levels of N,N-dimethyltryptamine following administrat... Psychopharmacologia 1974
Yensen R The Use of 3, 4 Methylenedioxyamphetamine (MDA) as an Adjunct to Brief... Dissertation UC Irvi... 1975
Abrahams SL, Nothup JK, M... Adenosine Cyclic 3',5'-Monophosphate in the Liver Fluke, fasciola hepa... Molec. Pharmacol. 1976
Belanger M, Chibon P, Cou... Etude radiologique des effets du LSD-25 sur l'amphibien pleurodeles wa... Compt.Rend.Soc.Biol. 1976
Enna SJ, Bennett JP, Burt... Stereospecificity of interaction of neuroleptic drugs with neurotransm... Nature 1976
Hamon M, Bourgoin S, Enja... The Effects of Quipazine on 5-HT Metabolism in the Rat Brain Naunyn Schmiedebergs... 1976
Kehr W Effect of Lisuride and Other Ergot Derivatives on Monoaminergic Neurot... Arch Pharmacol. 1977
Keller HH, Burkard WP, da... Lisuride and D-LSD: Effects on the monoaminergic system in the rat bra... Experientia 1977
Mansour TE, Mansour JM Phosphodiesterase in the Liver Fluke. Fasciola hevatica Biochem.Pharmacol. 1977
Menon MK, Clark WG, Masuo... Possible Involvement of the Central Dopaminergic System in the Antires... Psychopharmacology 1977
U'Prichard DC, Greenberg ... Binding Characteristics of a Radiolabeled Agonist and Antagonist at Ce... Mol.Pharmacol. 1977
Waldmeier PC, Maître L Neurochemical Investigations of the Interaction of N,N-Dimethyltryptam... Psychopharmacology 1977
Levi S, Reisfeld R Ultramcrodetermination of Cholesterol, Testosterone and LSD by Fluores... Analyt. Chim. Acta 1978
Rech RH Brain Lesions and Psychostimulant Drugs Psychopharmacol.Bull... 1978
Stolzki B, Kaiser HO, Meh... Heterogeneity of LSD Displacing Factors and Multiple Types of High Aff... Life Sci. 1978
Marshall DJ, Petersen BA,... Some Considerations on Quantitative Methodology and Detection Limits i... Biomed. Mass Spectro... 1978
Riceberg LJ, Vunakis HV Determination of N,N-dimethylindolealkylamines in plasma, blood and ur... J Pharmacol Exp Ther 1978
Geyer MA, Light RK, Rose ... A Characteristic Effect of Hallucinogens on Investigatory Responding i... Psychopharmacology 1979
Macdermot J, Higashida H Independent Regulation of Receptor-Mediated Cell Depolarization and Ad... Biochem. Soc. Trans. 1979
Nelson DL, Herbet A, Pich... In vitro and in vivo Disposition of 3H-Methiothepin in Brain Tissues. ... Arch.Pharmacol. 1979
Samanin R, Mennini T, Fer... m-Chlorophenylpiperazine: A Central Serotonin Agonist Causing Powerful... Naunyn-Schmiedeberg'... 1979
Connell DJ, Middlemiss DN... Further evidence for an interaction of propranolol with the central 5-... Brit.J.Pharmacol. 1980
Nichols DE, Lloyd DH, Hof... Effects of certain hallucinogenic amphetamine analogues on the release... J Med Chem 1982
Williams M, Martin GE Selectivity of cyproheptadine as assessed by radioligand binding J. Pharm.Pharmacol. 1982
Whipple MR, Reinecke MG, ... Short Communication: Inhibition of Synaptosomal Neurotransmitter Uptak... J. Neurochem. 1983
Leino M, Airaksinen MM, A... Distribution of 1,2,3,4-tetrahydro-beta-carboline and 6-methoxy-1,2,3,... Acta Pharmacol Toxic... 1984
Adams LM, Geyer MA Effects of DOM and DMT in a proposed animal model of hallucinogenic ac... Prog Neuropsychophar... 1985
Hryhorczuk LM, Rainey JM,... A new metabolic pathway for N,N-dimethyltryptamine Biol Psychiatry 1986
Fitzgerald RL, Blanke RV,... Determination of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxym... J Chromatogr 1989
Sadzot B, Baraban JM, Gle... Hallucinogenic drug interactions at human brain 5-HT2 receptors: impli... Psychopharmacology (... 1989
Callaway CW, Wing LL, Gey... Serotonin release contributes to the locomotor stimulant effects of 3,... J Pharmacol Exp Ther 1990
Wright JD, Pearl L Knowledge and experience of young people regarding drug abuse, 1969-89 BMJ 1990
Callaway CW, Johnson MP, ... Amphetamine derivatives induce locomotor hyperactivity by acting as in... Psychopharmacology (... 1991
Callaway CW, Geyer MA Stimulant effects of 3,4-methylenedioxymethamphetamine in the nucleus ... Eur J Pharmacol 1992
Michel RE, Rege AB, Georg... High-pressure liquid chromatography/electrochemical detection method f... J Neurosci Methods 1993
Rempel NL, Callaway CW, G... Serotonin1B receptor activation mimics behavioral effects of presynapt... Neuropsychopharmacol... 1993
Norton SA, Ruze P Kava Dermopathy J Am Acad Dermatol 1994
Wotherspoon G, Savery D, ... Repeated administration of MDMA down-regulates preprocholecystokinin m... Brain Res Mol Brain ... 1994
Marona-Lewicka D, Rhee GS... Psychostimulant-like effects of p-fluoroamphetamine in the rat Eur J Pharmacol 1995
Burns N, Olverman HJ, Kel... Effects of ecstasy on aldosterone secretion in the rat in vivo and in ... Endocr Res 1996
Geyer MA Serotonergic functions in arousal and motor activity Behav Brain Res 1996
Kombian SB, Zidichouski J... GABAB receptors presynaptically modulate excitatory synaptic transmiss... J Neurophysiol 1996
Callaway JC, Raymon LP, H... Quantitation of N,N-dimethyltryptamine and harmala alkaloids in human ... J Anal Toxicol 1996
Tillmann HL, van Pelt FN,... Accidental intoxication with methylene dianiline p,p'-diaminodiphenylm... J Toxicol Clin Toxic... 1997
Marquet P, Lacassie E, Ba... Simultaneous determination of amphetamine and its analogs in human who... J Chromatogr B Biome... 1997
Piscopo G Kava Kava: Gift of the Islands Alt Med Rev 1997
Walker TM, Davenport-Jone... The neurotoxic effects of methylenedioxymethamphetamine (MDMA) and its... Cell Biol Toxicol 1999
Laviola G, Adriani W, Ter... Psychobiological risk factors for vulnerability to psychostimulants in... Neurosci Biobehav Re... 1999
de la Torre R, Farré M, O... Non-linear pharmacokinetics of MDMA (`ecstasy') in humans Br J Clin Pharmacol 2000
de la Torre R, Farre M, O... Non-linear pharmacokinetics of MDMA ('ecstasy') in humans Br J Clin Pharmacol 2000
Connor TJ, Kelly JP, McGe... Methylenedioxymethamphetamine (MDMA; Ecstasy) suppresses IL-1b and TNF... Life Sci 2000
Connor TJ , Kelly JP, Leo... An assessment of the acute effects of the serotonin releasers methylen... Immunopharmacology 2000
Beitia G, Cobreros A, Sai... Ecstasy-induced Toxicity in Rat Liver Liver 2000
Clauwaert KM, Van Bocxlae... Determination of the designer drugs 3, 4-methylenedioxymethamphetamine... Clin Chem 2000
Felscher D, Schulz K Screening of Amphetamine/Methamphetamine and their Derivatives in Urin... J Forensic Sci 2000
Hernandez SC, Bertolino M... Dextromethorphan and its metabolite dextrorphan block alpha3beta4 neur... J Pharmacol Exp Ther 2000
Lee S-J, Chung H-Y, Lee I... Phenolics with Inhibitory Activity on Mouse Brain Monoamine Oxidase (M... Food Sci Biotechnol 2000
Ishibashi H, Kuwano K, Ta... Inhibition of the 5-HT(1A) receptor-mediated inwardly rectifying K(+) ... Neuropharmacology 2000
Clauwaert KM, Van Bocxlae... Determination of the designer drugs 3, 4-methylenedioxymethamphetamine... Clin Chem 2000
Mayerhofer A, Kovar KA, S... Changes in serotonin, dopamine and noradrenaline levels in striatum an... Neuroscience Letters 2001
Connor TJ, Connelly DB, K... Methylenedioxymethamphetamine (MDMA, 'Ecstasy') suppresses antigen-spe... Immunology Letters 2001
Cannon DM, Keenan AK, Gui... In vitro neuronal and vascular responses to 5-HT in rats chronically e... Br J Pharmacol 2001
Campo JV, McNabb J, Perel... Kava-induced fulminant hepatic failure J Am Acad Child Adol... 2002
Moeller MR, Kraemer T Drugs of abuse monitoring in blood for control of driving under the in... Ther Drug Monit 2002
Morley-Fletcher S, Bianch... Acute and carryover effects in mice of MDMA ('ecstasy') administration... Eur J Pharmacol 2002
Boatto G, Faedda MV, Pau ... Determination of amphetamines in human whole blood by capillary electr... J Pharm Biomed Anal 2002
Lieb R, Schuetz, CG, Pfis... Mental disorders in ecstasy users; A prospective-longitudinal investig... Drug Alcohol Depend 2002
Wachtel SR, ElSohly MA, R... Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol ... Psychopharmacology (... 2002
Meyer A, Mayerhofer A, Ko... Enantioselective metabolism of the designer drugs 3,4-methylenedioxyme... Neurosci Lett 2002
Kupiec T, DeCicco L, Spie... Choice of an ELISA assay for screening postmortem blood for amphetamin... J Anal Toxicol 2002
Cole JC, Bailey M, Sumnal... The content of ecstasy tablets: implications for the study of their lo... Addiction 2002
Cole JC, Bailey M, Sumnal... The content of ecstasy tablets: implications for the study of their lo... Addiction 2002
Buchert R, Thomasius R, N... Long-Term Effects of "Ecstasy" Use on Serotonin Transporters of the Br... J Nucl Med 2003
Peters FT, Schaefer S, St... Screening for and validated quantification of amphetamines and of amph... J Mass Spectrom 2003
Schneider RC, Kovar KA Analysis of ecstasy tablets: comparison of reflectance and transmittan... Forensic Sci Int 2003
Freudenmann RW, Spitzer M The Neuropsychopharmacology and Toxicology of 3,4-methylenedioxy-N-eth... CNS Drug Rev 2004
Halpern JH, Pope HG Jr, S... Residual neuropsychological effects of illicit 3,4-methylenedioxymetha... Drug Alcohol Depend 2004
Wang X, Baumann MH, Xu H,... 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decrea... Synapse 2004
Johansen SS, Jensen JL Liquid chromatography-tandem mass spectrometry determination of LSD, I... J Chromatogr B Analy... 2005
Ding EL, Hutfless SM, Din... Chocolate and prevention of cardiovascular disease: a systematic revie... Nutr Metab (Lond) 2006
Safarinejad MR, Hosseini ... Safety and efficacy of tramadol in the treatment of premature ejaculat... J Clin Psychopharmac... 2006
Williard RL, Middaugh LD,... Methylphenidate and its ethanol transesterification metabolite ethylph... Behav Pharmacol 2007
Alves E, Summavielle T, A... Monoamine Oxidase-B Mediates Ecstasy-Induced Neurotoxic Effects to Ado... J Neuroscience 2007
Schifano F, Corkery J, Na... Overview of Amphetamine-Type Stimulant Mortality Data - UK, 1997-2007 Neuropsychobiology 2010
Brandt SD, Sumnall HR, Me... Analyses of second-generation 'legal highs' in the UK: Initial finding... Drug Test Anal 2010
Cozzi NV, Mavlyutov TA, T... Indolethylamine N-methyltransferase expression in primate nervous tiss... Soc. Neurosci. 2011
Casselman I, Heinrich M Novel Use Patterns of Salvia divinorum: Unobtrusive Observation using ... Journal of Ethnophar... 2011
Gibbons S 'Legal Highs' - novel and emerging psychoactive drugs: a chemical over... Clin Toxicol (Phila) 2012
Lurie Y, Gopher A, Lavon ... Severe paramethoxymethamphetamine (PMMA) and paramethoxyamphetamine (P... Clin Toxicol (Phila) 2012
Carhart-Harris RL, Leech ... Implications for psychedelic-assisted psychotherapy: a functional magn... Br J Psychiatry 2012

Page 1 of 2   /   110 Entries Returned
Pages:     
 1 
2 next